Medicare Enrolled
Dr. Steven Goodman, M.D.
Rheumatology · Delray Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Goodman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goodman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Goodman
Dr. Steven Goodman is a rheumatology specialist in Delray Beach, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Goodman performed 145,116 Medicare services across 7,801 unique beneficiaries.
Between the years covered by Open Payments, Dr. Goodman received a total of $15,802 from 54 pharmaceutical and/or device companies across 859 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Goodman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 16% volume in FL
$15,802 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 68574 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗145,116
Medicare services
Top 16% in FL for rheumatology
7,801
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,638 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 41,360 | $5 | $7 |
| Certolizumab injection (Cimzia) | 27,400 | $4 | $12 |
| Romosozumab injection (Evenity) for osteoporosis | 22,680 | $8 | $12 |
| Denosumab injection (Prolia/Xgeva) | 18,660 | $18 | $25 |
| Abatacept infusion (Orencia) | 6,150 | $34 | $75 |
| Infliximab infusion (Remicade) | 5,930 | $26 | $100 |
| Steroid injection (triamcinolone) | 4,348 | $1 | $10 |
| Office visit, established patient (30-39 min) | 1,625 | $98 | $150 |
| Blood draw (venipuncture) | 1,011 | $8 | $10 |
| Calcium level, total | 928 | $5 | $8 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 899 | $59 | $100 |
| Methotrexate sodium, 5 mg | 862 | $0 | $5 |
| Blood creatinine level | 797 | $5 | $12 |
| Urea nitrogen level to assess kidney function, quantitative | 793 | $4 | $12 |
| Albumin (protein) level | 784 | $5 | $8 |
| Bilirubin level, total | 782 | $5 | $12 |
| Phosphatase (enzyme) level, alkaline | 782 | $5 | $15 |
| Liver enzyme (sgot), level | 782 | $5 | $15 |
| Liver enzyme (sgpt), level | 782 | $5 | $15 |
| Uric acid level test | 640 | $4 | $8 |
| Blood potassium level | 631 | $5 | $8 |
| Complete blood count (CBC) with differential | 627 | $8 | $31 |
| C-reactive protein test (inflammation marker) | 626 | $5 | $12 |
| Blood sodium level | 625 | $5 | $12 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 594 | $4 | $12 |
| Joint injection, major joint | 335 | $41 | $129 |
| Administration of chemotherapy into vein, 1 hour or less | 317 | $108 | $250 |
| Office visit, established patient (20-29 min) | 311 | $69 | $100 |
| Vitamin D level test | 306 | $29 | $55 |
| Measurement of antibody for assessment of autoimmune disorder, any method | 245 | $18 | $30 |
| Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) | 188 | $181 | $277 |
| Injection of trigger points, 1-2 muscles | 171 | $23 | $80 |
| Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve | 157 | $84 | $240 |
| Bone density scan (DEXA) | 156 | $39 | $125 |
| Complete blood count (CBC), automated | 150 | $6 | $18 |
| Administration of chemotherapy into vein, each additional hour | 139 | $23 | $75 |
| Injection into tendon or ligament | 123 | $33 | $90 |
| Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | 116 | $45 | $199 |
| Analysis of substance using immunoassay technique, multiple step method | 100 | $11 | $20 |
| New patient office visit (45-59 min) | 95 | $125 | $225 |
| Cardiolipin antibody (tissue antibody) measurement | 79 | $25 | $40 |
| X-ray of hand, minimum of 3 views | 74 | $29 | $50 |
| Knee X-ray, 3 views | 71 | $32 | $55 |
| Injection, zoledronic acid, 1 mg | 70 | $7 | $80 |
| X-ray of lower and sacral spine, 2-3 views | 67 | $31 | $65 |
| Shoulder X-ray, 2+ views | 64 | $28 | $50 |
| Aspiration and/or injection of fluid from medium joint | 61 | $41 | $100 |
| Screening test for autoimmune disorder | 58 | $12 | $25 |
| Hip X-ray, 2-3 views | 56 | $35 | $60 |
| Measurement of antibody for rheumatoid arthritis assessment | 55 | $13 | $25 |
| Rheumatoid factor level | 50 | $6 | $25 |
| X-ray of upper spine, 2-3 views | 42 | $30 | $60 |
| Measurement of dna antibody, native or double stranded | 35 | $13 | $30 |
| Measurement of dna antibody, single stranded | 34 | $12 | $20 |
| Injection of anesthetic agent and/or steroid into rib nerve | 33 | $70 | $230 |
| Injection of anesthetic agent and/or steroid into multiple rib nerves for regional nerve block | 33 | $26 | $340 |
| Measurement of complement (immune system proteins), antigen, | 32 | $12 | $30 |
| Measurement of complement function (immune system proteins) | 32 | $12 | $30 |
| Injection into tendon at attachment to bone or muscle | 27 | $31 | $90 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 27 | $53 | $115 |
| X-ray of wrist, minimum of 3 views | 25 | $34 | $55 |
| Injection of carpal tunnel | 22 | $76 | $129 |
| X-ray of middle spine, 3 views | 22 | $33 | $65 |
| X-ray of ankle, 2 views | 16 | $26 | $45 |
| X-ray of elbow, 2 views | 12 | $24 | $45 |
| X-ray of both hips, 3-4 views | 12 | $44 | $75 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.3% high complexity
80.7% medium
10.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,802
Total received (2018-2024)
Avg $2,257/year across 7 years
Top 31% in FL for rheumatology
54
Companies
859
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,779 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$23 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,631
2023
$2,433
2022
$2,061
2021
$2,245
2020
$1,503
2019
$2,242
2018
$2,687
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,280
GlaxoSmithKline, LLC.
$1,356
Novartis Pharmaceuticals Corporation
$1,329
UCB, Inc.
$1,046
ABBVIE INC.
$995
E.R. Squibb & Sons, L.L.C.
$982
PFIZER INC.
$962
Janssen Biotech, Inc.
$855
Boehringer Ingelheim Pharmaceuticals, Inc.
$566
Radius Health, Inc.
$560
Lilly USA, LLC
$413
AstraZeneca Pharmaceuticals LP
$410
Genentech USA, Inc.
$405
Mallinckrodt Hospital Products Inc.
$396
Mallinckrodt LLC
$316
AbbVie Inc.
$292
SANOFI-AVENTIS U.S. LLC
$266
AbbVie, Inc.
$262
Celgene Corporation
$238
Mallinckrodt Enterprises LLC
$186
GENZYME CORPORATION
$180
Sobi, Inc
$159
Alvogen Inc
$137
Horizon Therapeutics plc
$124
DePuy Synthes Sales Inc.
$113
SOBI, INC
$108
Aurinia Pharma U.S., Inc.
$90
Actelion Pharmaceuticals US, Inc.
$86
Alexion Pharmaceuticals, Inc.
$56
Fresenius Kabi USA, LLC
$52
Orthogenrx Inc.
$47
Ultragenyx Pharmaceutical Inc.
$44
Kyowa Kirin, Inc.
$42
Flexion Therapeutics, Inc.
$42
ANI Pharmaceuticals, Inc.
$34
West-Ward Pharmaceuticals
$33
Horizon Pharma plc
$30
Organon Llc
$29
Abbott Laboratories
$27
Hikma Pharmaceuticals USA
$26
Celltrion USA Inc.
$23
TerSera Therapeutics LLC
$22
SCILEX PHARMACEUTICALS INC.
$20
Cumberland Pharmaceuticals, Inc.
$19
Kowa Pharmaceuticals America, Inc.
$18
Teva Pharmaceuticals USA, Inc.
$17
Organon LLC
$17
Merck Sharp & Dohme Corporation
$15
MEDAC PHARMA, INC.
$14
Gilead Sciences, Inc.
$14
Eyevance Pharmaceuticals LLC
$13
Avion Pharmaceuticals
$12
Ironwood Pharmaceuticals, Inc
$12
Bioventus LLC
$11
Top 3 companies account for 31.4% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · Balcoltra · Bimzelx · COSENTYX · CRYSVITA · CYLTEZO · Cimzia · Crysvita · DUZALLO · ETERNA · EVENITY · EVUSHELD · Enbrel · FORTEO · GELSYN 3 · GenVisc 850 · HADLIMA · HUMIRA · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · MONOVISC · Mitigare · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · Otezla · PRIALT · PURIFIED CORTROPHIN GEL · Prolia · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · SYNVISC-ONE · Seglentis · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Truxima · Tymlos · XELJANZ · YUFLYMA · ZTLido · Zerviate · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $11 per 100 Medicare services performed
Geographic Context
Rheumatologists within 10 mi
58
Per 100K population
3.8
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Goodman is a mixed practice specialist, with above-average Medicare volume (top 16% in FL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Goodman experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Goodman performed 41,360 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Goodman receive payments from pharmaceutical companies?
Yes. Dr. Goodman received a total of $15,802 from 54 companies across 859 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goodman's costs compare to other rheumatologists in Delray Beach?
Dr. Goodman's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goodman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Delray Beach
Browse rheumatologists in Delray Beach ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in FL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in FL
Which FL rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology